コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 lial protein C receptor (EPCR) in hemophilic arthropathy.
2 l) and suffers from hemarthroses and chronic arthropathy.
3 ead to chronic disabilities with haemophilic arthropathy.
4 th effusion, meniscal tear, and degenerative arthropathy.
5 and knees, and may be associated with severe arthropathy.
6 tis, differentiating it from acute Charcot's arthropathy.
7 uromuscular disease, skeletal dysplasias and arthropathy.
8 s bleeding, with joint bleeds progressing to arthropathy.
9 thritis (RA) is the most common inflammatory arthropathy.
10 in musculoskeletal conditions, such as knee arthropathy.
11 mortality and morbidity of chronic crippling arthropathy.
12 bows, which can result in the development of arthropathy.
13 or as seen in hemophilia in general leads to arthropathy.
14 and prevention of foot ulcers and neurogenic arthropathy.
15 or anular hyperintense zone (HIZ), and facet arthropathy.
16 ritical to the development of B27-associated arthropathy.
17 ubrication is an early event in inflammatory arthropathy.
18 as it had been proposed to do in hemophilic arthropathy.
19 nfected individuals who presented with acute arthropathy.
20 d the relationship of chopsticks use to hand arthropathy.
21 al skin rash, and a characteristic deforming arthropathy.
22 and are associated with severe degenerative arthropathy.
23 y susceptible mouse can mimic B27-associated arthropathy.
24 J, and BALB/cJ beta2m(0) mice developed this arthropathy.
25 mino-transferase values, and hemochromatotic arthropathy.
26 tive arthritis, Reiter's syndrome, and other arthropathies.
27 nt enzymes and inhibitors in the destructive arthropathies.
28 patients with acromegaly, results in severe arthropathies.
29 ing of cartilage-subchondral interactions in arthropathies.
30 imulated renewed interest in crystal-induced arthropathies.
31 dvances in the management of crystal-induced arthropathies.
32 ial fluid samples from patients with various arthropathies.
33 argets for management of the crystal-induced arthropathies.
34 om patients with OA or other noninflammatory arthropathies.
35 s not associated with cancer or inflammatory arthropathy?
36 ncluding 14 patients with spinal neuropathic arthropathy (12 radiographic, seven CT, and six MR studi
38 axis use and its impact on key indicators of arthropathy across the life-span among participants with
39 iency protects against developing hemophilic arthropathy, administration of a single dose of EPCR-blo
40 anged from -0.2% (95% CI, -1.0% to 0.6%) for arthropathies among males to 23.9% (95% CI, 22.7%-25.0%)
41 s can reliably differentiate between chronic arthropathies and inflammatory conditions with discrete
43 ails in patients with more severe peripheral arthropathy and axial involvement, and alternative treat
44 crystal deposition diseases (including gouty arthropathy and calcium pyrophosphate deposition disease
48 ted with human aging-associated degenerative arthropathy and directly stimulate chondrocalcinosis, ma
49 s not associated with cancer or inflammatory arthropathy and do not apply to the management of acute
51 with EPCR in the pathogenesis of hemophilic arthropathy and its treatment with recombinant FVIIa (rF
54 autosomal-dominant human motor neuropathies, arthropathies, and skeletal malformations of varying sev
55 an be affected by many types of inflammatory arthropathies, and the most common autoimmune diseases w
59 sis; multicentric osteolysis, nodulosis, and arthropathy; and Winchester syndromes, skeletal dysplasi
62 is, including poor general health, diabetes, arthropathies, arrhythmias, impotence, and skin pigmenta
63 e participant, who had substantial, advanced arthropathy at baseline, administered factor for bleedin
65 members had multiple shoulder, hip, and knee arthropathies, beginning in the pre-teen years and conti
66 atients with already existing advanced joint arthropathy benefit from tertiary prophylaxis with signi
68 ay that has been associated with neuropathic arthropathy but has not been assessed in knee osteoarthr
69 ints is closely associated with OA and other arthropathies, but the precise role of HA in arthritis p
70 inflammation seen in primary osteoarthritis, arthropathy caused by excess GH affects all joint tissue
73 f-function mutations result in camptodactyly-arthropathy-coxa vara-pericarditis (CACP) syndrome, whic
75 e autosomal recessive disorder camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP; MIM 2
77 athy and vascular disease (DI), with Charcot arthropathy (DA), and without complications (D), and in
79 Tendon diseases are among the most common arthropathy disorders; thus knowledge of tendon gene reg
80 lupus erythematosus, and a group of chronic arthropathies, expression of CD44-dependent primary adhe
84 en bleeding occurs in the joints, hemophilic arthropathy (HA) may develop, resulting in hemarthroses
85 tion in the knee joint tissues of hemophilic arthropathy (HA) patients using quantitative susceptibil
88 tervertebral discs, bulging, and facet joint arthropathy have been documented in almost 90% of asympt
91 a, a congenital bleeding disorder, can cause arthropathy, impaired mobility, pain, and life-threateni
98 any of the first descriptions of crystalline arthropathies, including gout, calcium pyrophosphate dep
99 olderia cepacia, and cystic fibrosis-related arthropathy increased the post-transplantation hazard of
100 s; unspecified/mixed CTD; other inflammatory arthropathy), increased ASCVD rates were found in nearly
102 esting as cutaneous vasculitis, inflammatory arthropathy, intermittent polyclonal lymphoproliferation
105 f events from joint bleeding to synovitis to arthropathy is well documented, the component or compone
106 = 0.55), Modic changes (kappa = 0.59), facet arthropathy (kappa = 0.54), and posterior HIZ (kappa = 0
107 = 0.74), Modic changes (kappa = 0.64), facet arthropathy (kappa = 0.69), and posterior HIZ (kappa = 0
108 te and chronic parvoviral B19 infections and arthropathy may provide insights into virus-host interac
109 rding rubella as a possible cause of chronic arthropathy, more negative evidence accumulated with two
112 diopathic skeletal hyperostosis, crystalline arthropathy, neuropathic arthropathy, and tendinopathy.
114 An unusual destructive and hypertrophic arthropathy of the atlantoaxial joint in calcium pyropho
115 images in patients with diabetic neuropathic arthropathy of the foot were examined by two reviewers i
116 e of any increased risk of new onset chronic arthropathies or neurologic conditions in women receivin
119 elated systemic pathology (e.g., early onset arthropathy, premature aging, ovulation, late onset of p
120 sorders) and 9 disease outcomes (gout, gouty arthropathy, pyogenic arthritis, essential hypertension,
122 Patients with the systemic inflammatory arthropathy, rheumatoid arthritis (RA), were evaluated a
123 arthritis (RR 4.9 [2.7-7.6]) or inflammatory arthropathy (RR 1.4 [1.2-1.7]), operation under general
125 nti-IL-17 antibody prevented the destructive arthropathy seen in vaccinated and challenged IFN-gamma(
126 CHIKV disease, usually a self-limiting viral arthropathy, share multiple inflammatory processes.
127 study suggest that treatment of acromegalic arthropathy should involve inhibition of ectopic chondro
131 were less likely to be seen for nontraumatic arthropathies than nonpostpartum women (4.5% vs 7.2%, P=
132 rthritis is a heterogeneous group of chronic arthropathies that are influenced by complex genetic and
136 joint has been referred to as an "analgesic arthropathy." This article discusses common treatments o
141 findings for diagnosis of spinal neuropathic arthropathy were vacuum disk on radiographs and CT image
142 me assessment as an indicator of early joint arthropathy when followed by ultrasound or magnetic reso
144 y represent a familial type of pyrophosphate arthropathy with a phenotype that includes peripheral an
145 d rubella vaccine in the US and some chronic arthropathy with an onset between 1 week and 6 weeks aft